<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="52836">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02418338</url>
  </required_header>
  <id_info>
    <org_study_id>9458</org_study_id>
    <nct_id>NCT02418338</nct_id>
  </id_info>
  <brief_title>2D Strain Evaluation: Children With Duchenne Muscular Dystrophy Versus Healthy Children</brief_title>
  <official_title>Evaluation of Myocardial Function by Two Dimensional Speckle Tracking Echocardiography in Children With Duchenne Muscular Dystrophy Versus Healthy Children: a Comparative Transversal Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Compare systolic function of left ventricle (LV) and right ventricle (VD) by 2D strain
      evaluation in Duchenne muscular dystrophy children versus a control group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Among the new echocardiographic techniques, two dimensional Speckle Tracking Imaging or &quot;2D
      Strain&quot; allows a dynamic study of regionalized and global ventricular contraction. With
      software for the spatial and temporal processing of a standard 2D image, this technique
      measures the displacement of natural markers present on the myocardial wall.

      Used in adult cardiology since 2000, it could be eligible to pediatric population because of
      many potential applications. In Duchenne muscular dystrophy, myocardial disease leads to
      death in the third decade. Early diagnosis and preventive therapy remain a challenge. No
      clinic, biologic or radiologic markers can predict myocardial disease before advanced and
      irreversible heart failure.

      Recent animals and human studies suggest that 2D strain anomalies could predict left
      ventricular systolic dysfunction in Duchenne muscular dystrophy. If it is confirmed, 2D
      strain could be used as early marker of myocardial disease in routine patient follow-up and
      in future therapeutic studies.

      Purpose : - To compare systolic function of left ventricle (LV) and right ventricle (RV) by
      2D strain evaluation in Duchenne muscular dystrophy children versus a control group.

        -  To correlate 2D Strain variables to conventional LV and RV echo variables.

        -  To evaluate 2D strain feasibility in normal children and Duchenne muscular myopathy
           population
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>global longitudinal LV 2D strain</measure>
    <time_frame>day 1</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">99</enrollment>
  <condition>Duchenne Muscular Dystrophy</condition>
  <arm_group>
    <arm_group_label>dmd children</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>echocardiography</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy children</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>echocardiography</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>speckle tracking (2D strain) echocardiography</intervention_name>
    <description>2D echocardiography videos of both ventricles to perform 2D strain post-examination evaluation</description>
    <arm_group_label>dmd children</arm_group_label>
    <arm_group_label>healthy children</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Duchenne's muscular dystrophy (group 1) followed in our institution's referral center
             of neuromuscular diseases, during regular annual echocardiography follow-up.

          -  Healthy children (group 2), addressed in pediatric cardiology
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cardiology paediatric consultation, Arnaud de Villeneuve Hospital</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascal AMEDRO, MD</last_name>
      <phone>+33 4 67 33 66 39</phone>
      <email>p-amedro@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Pascal AMEDRO, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <lastchanged_date>January 25, 2016</lastchanged_date>
  <firstreceived_date>April 13, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Muscular Dystrophies</mesh_term>
    <mesh_term>Muscular Dystrophy, Duchenne</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
